|

Givastomig Clinical Trials

1 actively recruiting trial across 1 location

Also known as: TJ033721

Pipeline

Phase 2: 1

Top Sponsors

  • I-Mab Biopharma US Limited1

Indications

  • Gastroesophageal Junction Carcinoma1
  • Advanced Cancer1
  • Esophageal Adenocarcinoma1
  • Metastatic Cancer1
  • Solid Tumor1

Goodyear, Arizona1 trial

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

I-Mab Site 1016

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.